Stockreport

Fulcrum Therapeutics Touts PIONEER HbF Gains, Early VOC Signal; FDA Path and Accelerated Approval Talk [Yahoo! Finance]

Fulcrum Therapeutics, Inc.  (FULC) 
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am Check Earnings Report
PDF 7.1% to 19.3% over 12 weeks, ?12.2), improvement in hemolysis markers, and an early vaso-occlusive crisis (VOC) reduction signal (6 VOCs observed vs. 16 expected; 7 of 1 [Read more]